expert perspectives

in Plaque Psoriasis

Expert Perspectives in Plaque Psoriasis to Cover Key Topics in Plaque Psoriasis Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Plaque Psoriasis will feature selected topics in Plaque Psoriasis that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Steven R. Feldman, MD, PhD

Professor of Dermatology, Pathology, and Social Sciences & Health Policy
Wake Forest School of Medicine
Winston-Salem, NC 

Joel M. Gelfand, MD, MSCE

Professor of Dermatology and Epidemiology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

Alice B. Gottlieb, MD, PhD

Clinical Professor and Medical Director
Mount Sinai Beth Israel Hospital
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY


Community-Selected Topics:

Expert Roundtables 

    Biologic Switching in the Treat-to-Target Paradigm of Plaque Psoriasis
    Taking on the Systemic Inflammatory Burden of Psoriasis
    Defining Success in Psoriasis Care: Treatment Expectations and Clinical Goals
    Evidence-Based Medicine on Laboratory Monitoring for Biologics  

Clinical Topic Updates 

    Current Data on Interleukin-23 Inhibition in the Clinical Spectrum of Psoriasis
    Biologics and Pregnancy
    COVID-19 Vaccination in Patients With Psoriasis
    Best Biologic Choices After Therapeutic Failure on a Biologic

Patient Care Perspectives 

    Dosing Preferences and Patient Satisfaction With Plaque Psoriasis Therapies
    Helping Patients to Use Their Psoriasis Medications as Recommended
    Obesity and Metabolic Health in Patients With Psoriasis
    Counseling the Newly Diagnosed Patient With Moderate to Severe Plaque Psoriasis  

More in Plaque Psoriasis

Thumb

Plaque Psoriasis

Interleukin-23p19 Inhibitors: Current Perspectives

clinical topic updates by Alice B. Gottlieb, MD, PhD

Selective inhibitors of the interleukin-23p19 (IL-23p19) subunit have emerged as highly effective therapies for patients with moderate to severe pl...READ MORE

Thumb

Plaque Psoriasis

TNF Inhibitor–Induced Psoriasis

clinical topic updates by Steven R. Feldman, MD, PhD

Psoriasis induced by tumor necrosis factor–α  inhibitor (TNFi) therapy is a relatively uncommon side effect that may occur during the treatment of ...READ MORE

Thumb

Plaque Psoriasis

Psoriasis Flare or Diminishing Response to Treatment?

patient care perspectives by Steven R. Feldman, MD, PhD

In patients with psoriasis, a disease flare may result from a loss of response (eg, due to antidrug antibodies), increased disease activity, or adh...READ MORE

More In Dermatology

Plaque Psoriasis

Dosing Preferences and Patient Satisfaction With Plaque Psoriasis Therapies

clinical topic updates
by Steven R. Feldman, MD, PhD

Plaque Psoriasis

Current Data on Interleukin-23 Inhibition in the Clinical Spectrum of Psoriasis

clinical topic updates
by Alice B. Gottlieb, MD, PhD

Plaque Psoriasis

Moving Toward More Precisely Targeted Therapies for Plaque Psoriasis

expert roundtables
by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD